[1]
S. Molinaro et al., “Adherence to Oral Molecular Targeted Therapy in Metastatic Renal Cell Carcinoma: A Qualitative Study”, IJHS, vol. 1, no. Suppl. 2, pp. 262–263, Sep. 2026, Accessed: Nov. 01, 2026. Available: https://journals.ieditore.com/index.php/IJHS/article/view/631